Moxifloxacin concentration correlate with QTc interval in rifampicin-resistant tuberculosis patients on shorter treatment regimens

BACKGROUND: Drug-resistant tuberculosis (DR-TB) continues to be a global threat. Moxifloxacin is one of the components of the shorter treatment regimen which is suspected to increase the risk of QT prolongation, although it is also likely to be the most effective against DR-TB. A study to evaluate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusmiati, Tutik, Made Mertaniasih, Ni, Nugroho Eko Putranto, Johanes, Suprapti, Budi, Luthfah, Nadya, Soedarsono, Soedarsono, Koesoemoprodjo, Winariani, Prawita Sari, Aryani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189108/
https://www.ncbi.nlm.nih.gov/pubmed/35706565
http://dx.doi.org/10.1016/j.jctube.2022.100320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189108/
https://www.ncbi.nlm.nih.gov/pubmed/35706565
http://dx.doi.org/10.1016/j.jctube.2022.100320

Ejemplares similares